Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H (3378) Revenue

― Followers

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H Revenue

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H had a revenue of 3.48B in the quarter ending Jun 30, 2019, with 0.00%. This bring the company's revenue in the last twelve months to 6.97B, Decreased 3.79%. In the fiscal year ending Dec 31, 2021, Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H had annual revenue of 25.69B with 45.21% growth.

Revenue (ttm)

6.97B

Revenue Growth

―

P/S Ratio

0.15

Revenue/Employee

HK$428,168,533

Employees

Market Cap

HK$3.75B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2021	25.69B	8.00B	+45.21%
Dec 31, 2020	17.69B	3.76B	+26.98%
Dec 31, 2019	13.93B	1.02B	+7.87%
Dec 31, 2018	12.92B	-5.56M	-0.04%
Dec 31, 2017	12.92B	―	―